When, for reasons of toleration, combination therapy with methotrexate is not possible, what is the role of biologic agents, including IL-6 inhibitors, as part of monotherapeutic regimen?

When, for reasons of toleration, combination therapy with methotrexate is not possible, what is the role of biologic agents, including IL-6 inhibitors, as part of monotherapeutic regimen?

When, for reasons of toleration, combination therapy with methotrexate is not possible, what is the role of biologic agents, including IL-6 inhibitors, as part of monotherapeutic regimen?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Eric Ruderman, MD

Eric Ruderman, MD

Professor of Medicine
Division of Rheumatology
Northwestern University, Feinberg School of Medicine
Chicago, Illinois